Protagonist Therapeutics PTGX
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: −$2.50M (10 inflow days, 10 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 44.4% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 12.04% to 15.83% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| UBS Asset Management | Mutual Fund | 2026/Q3 | +554,015 | 6.2% |
| FMR | Mutual Fund | 2026/Q3 | +403,349 | 1.6% |
| Stephens Investment Management Group, LLC | Mutual Fund | 2026/Q3 | +186,670 | 0.7% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +157,713 | 5.3% |
| Public Sector Pension Investment Board | Government Pension Fund | 2026/Q3 | +118,193 | 0.5% |
| Russell Investment Management, LLC | Mutual Fund | 2026/Q3 | +99,352 | 0.3% |
| Ranger Investment Management, L.P. | Mutual Fund | 2026/Q3 | +82,362 | 0.1% |
| Renaissance Technologies Corp. | Hedge Fund | 2026/Q3 | +76,967 | 0.1% |
| BlackRock | Mutual Fund | 2026/Q3 | +528,468 | 15.9% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +484,165 | 3.3% |
| Putnam LLC | Mutual Fund | 2026/Q3 | +382,425 | 0.7% |
| Alyeska Investment Group, L.P. | Hedge Fund | 2026/Q3 | +296,101 | 1.4% |
| Stephens Investment Management Group, LLC | Mutual Fund | 2026/Q3 | +281,832 | 0.4% |
| Lord, Abbett & Co. LLC | Mutual Fund | 2026/Q3 | +235,535 | 0.6% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +204,805 | 5.1% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 29 Sep 2026 | Asif Ali | Chief Financial Officer | Derivative Exercise and Sale | -58,629 | $141.78 | 2,569 |
| 9 Sep 2026 | Dinesh Patel | CEO, President, Secretary & Director | Derivative Exercise and Sale | -125,000 | $146.18 | 286,926 |
| 2 Sep 2026 | Dinesh Patel | CEO, President, Secretary & Director | Other Disposition | -510 | – | 286,926 |
| 10 Aug 2026 | Dinesh Patel | CEO, President, Secretary & Director | Derivative Exercise and Sale | -100,000 | $149.11 | 287,436 |
| 22 Jun 2026 | William Waddill | Independent Director | Derivative Exercise and Sale | -9,000 | $117.94 | 5,130 |
| 9 Jun 2026 | William Waddill | Independent Director | Derivative Exercise and Sale | -9,000 | $107.68 | 5,130 |
| 28 May 2026 | William Waddill | Independent Director | Derivative Exercise and Sale | -9,000 | $99.64 | 5,130 |
| 11 May 2026 | Dinesh Patel | CEO, President, Secretary & Director | Derivative Exercise and Sale | -75,000 | $100.12 | 287,436 |
| 7 May 2026 | Bryan Giraudo | Independent Director | Open Market Disposition | -23,130 | $100.07 | 10,000 |
| 6 May 2026 | Bryan Giraudo | Independent Director | Derivative Exercise and Sale | -36,000 | $100.14 | 10,000 |
| 22 Apr 2026 | Dinesh Patel | CEO, President, Secretary & Director | Other Disposition | -1,460 | – | 287,436 |
| 19 Apr 2026 | Asif Ali | Chief Financial Officer | Open Market Disposition | -1,750 | $105.47 | 2,569 |
| 25 Mar 2026 | Harold Selick | Independent Chairperson | Derivative Exercise and Sale | -24,000 | $105.00 | 58,150 |
| 25 Mar 2026 | Arturo Molina | Chief Medical Officer | Derivative Exercise and Sale | -15,000 | $104.79 | 13,637 |
| 25 Mar 2026 | Asif Ali | Chief Financial Officer | Derivative Exercise and Sale | -24,765 | $104.24 | 4,319 |
| 24 Mar 2026 | Dinesh Patel | CEO, President, Secretary & Director | Derivative Exercise and Sale | -54,700 | $101.00 | 288,896 |
| 22 Mar 2026 | Dinesh Patel | CEO, President, Secretary & Director | Other Disposition | -50,000 | – | 288,896 |
| 16 Feb 2026 | Lewis Williams | Independent Director | Derivative Exercise and Sale | -18,000 | $82.42 | 5,130 |
| 5 Feb 2026 | William Waddill | Independent Director | Derivative Exercise and Sale | -20,000 | $83.68 | 5,130 |
| 26 Jan 2026 | Arturo Molina | Chief Medical Officer | Intent to Sell (Form 144) | -5,000 | $82.00 | – |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 10,242,340 | 15.8% | 16.9 |
| 15 Oct 2026 | 10,297,224 | 15.9% | 12.0 |
| 30 Sep 2026 | 9,345,382 | 14.4% | 11.5 |
| 15 Sep 2026 | 8,140,194 | 12.6% | 15.1 |
| 31 Aug 2026 | 7,712,543 | 11.9% | 15.3 |
| 14 Aug 2026 | 7,791,795 | 12.0% | 16.4 |
No comments yet — be the first to weigh in on PTGX.
Sign in to join the discussion.